Dextromethorphan and guaifenesin use must be monitored meticulously in clients with "very poor metabolizer" CYP2D6 enzyme amounts and patients who're sedated. This mix medication has a big median toxic dose (TD50) to median successful dose (ED50) ratio (or therapeutic index) in these patients. Dextromethorphan and guaifenesin may cause neonatal gasping https://socialislife.com/story3544391/the-best-side-of-dextromethorphan-dxm-for-sale